| NCT Number | NCT07548853 |
| Lead Sponsor | Taisho Pharmaceutical Co., Ltd. |
| Conditions | Hyperphosphatemia Patients on Peritoneal Dialysis |
| Enrollment | 30 participants |
| Start Date | 2026-05-13 |
| Primary Completion | 2027-05-31 (estimated) |
| Study Completion | 2027-05-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-10 |